• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 research in critical care: the good, the bad, and the ugly.

作者信息

Salluh Jorge I F, Arabi Yaseen M, Binnie Alexandra

机构信息

Department of Critical Care and Postgraduate Program in Translational Medicine, D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.

Programa de Pós-Graduação em Clínica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

Intensive Care Med. 2021 Apr;47(4):470-472. doi: 10.1007/s00134-021-06367-5. Epub 2021 Mar 1.

DOI:10.1007/s00134-021-06367-5
PMID:33646318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7917526/
Abstract
摘要

相似文献

1
COVID-19 research in critical care: the good, the bad, and the ugly.危重症护理中的新冠病毒疾病研究：好的、坏的与不堪的方面。
Intensive Care Med. 2021 Apr;47(4):470-472. doi: 10.1007/s00134-021-06367-5. Epub 2021 Mar 1.
2
Translating stem cells to the clinic: the good, the bad, and the ugly.将干细胞应用于临床：好的方面、坏的方面与丑陋的方面。
Ann Neurol. 2008 Mar;63(3):A17-21. doi: 10.1002/ana.21253.
3
[Clinical research in COVID-19 era].[新冠疫情时代的临床研究]
Rev Med Chil. 2020 May;148(5):707-708. doi: 10.4067/S0034-98872020000500707.
4
Impact of clinical and patient pathway changes on paediatric research during the national COVID-19 response.国家应对新冠疫情期间临床及患者诊疗路径变化对儿科研究的影响
Arch Dis Child. 2021 Dec;106(12):e50. doi: 10.1136/archdischild-2021-322865. Epub 2021 Aug 24.
5
Impact of COVID-19 on health services, vascular surgery and medical research.2019冠状病毒病对卫生服务、血管外科和医学研究的影响。
Int Angiol. 2021 Jun;40(3):177-179. doi: 10.23736/S0392-9590.21.04623-X. Epub 2021 Feb 12.
6
Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward.2019冠状病毒病对胰腺癌研究的影响及未来方向
Gastroenterology. 2021 Dec;161(6):1758-1763. doi: 10.1053/j.gastro.2021.06.080. Epub 2021 Aug 10.
7
The ugly, the bad and the good: Reflections on a COVID-19-devastated year.丑恶、糟糕与美好：对新冠疫情肆虐之年的反思
Waste Manag Res. 2021 Jun;39(1_suppl):1-2. doi: 10.1177/0734242X211024386. Epub 2021 Jun 2.
8
COVID-19 Pandemic: A Wake-Up Call for Indian Medical Research.新冠疫情：给印度医学研究的一记警钟。
Neurol India. 2021 Mar-Apr;69(2):513-514. doi: 10.4103/0028-3886.314586.
9
Non-Covid-19 clinical research in the era of pandemic.大流行时代的非新冠病毒临床研究。
Am J Emerg Med. 2021 Jan;39:231-232. doi: 10.1016/j.ajem.2020.05.013. Epub 2020 May 8.
10
Covid-19 and the Investigator Pipeline.新冠疫情与研究人员储备
N Engl J Med. 2021 Jul 1;385(1):7-9. doi: 10.1056/NEJMp2100086. Epub 2021 Mar 24.

引用本文的文献

1
Efficacy of COVID-19 Treatments in Intensive Care Unit: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.新型冠状病毒肺炎（COVID-19）重症监护治疗的疗效：随机对照试验的系统评价和荟萃分析
Crit Care Res Pract. 2024 Nov 27;2024:2973795. doi: 10.1155/ccrp/2973795. eCollection 2024.
2
COVID-19 Pandemic and Impact on Research Publications in Critical Care.COVID-19 大流行及其对危重病研究出版物的影响。
Crit Care Explor. 2024 Jun 5;6(6):e1103. doi: 10.1097/CCE.0000000000001103. eCollection 2024 Jun.
3
Structural under-reporting of informed consent, data handling and sharing, ethical approval, and application of Open Science principles as proxies for study quality conduct in COVID-19 research: a systematic scoping review.结构信息缺失，包括知情同意、数据处理和共享、伦理审批，以及开放科学原则在 COVID-19 研究中作为研究质量行为的替代指标：系统范围审查。
BMJ Glob Health. 2023 May;8(5). doi: 10.1136/bmjgh-2023-012007.
4
The positive impact of COVID-19 on critical care: from unprecedented challenges to transformative changes, from the perspective of young intensivists.新冠疫情对重症监护的积极影响：从前所未有的挑战到变革性变化，以年轻重症医学专家的视角
Ann Intensive Care. 2023 Apr 11;13(1):28. doi: 10.1186/s13613-023-01118-9.
5
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?从细胞因子风暴到细胞因子微风：免疫发病机制的经验教训是否改善了中重度新冠肺炎的免疫调节治疗？
Biomedicines. 2022 Oct 18;10(10):2620. doi: 10.3390/biomedicines10102620.
6
Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study.与首次 COVID-19 浪潮期间死亡率相关的临床和组织因素：全球 UNITE-COVID 研究。
Intensive Care Med. 2022 Jun;48(6):690-705. doi: 10.1007/s00134-022-06705-1. Epub 2022 May 21.
7
The association between therapeutic plasma exchange and the risk of mortality among patients critically ill with COVID-19: a meta-analysis.治疗性血浆置换与 COVID-19 危重症患者死亡率之间的关联：一项荟萃分析。
F1000Res. 2021 Dec 14;10:1280. doi: 10.12688/f1000research.74972.1. eCollection 2021.
8
Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19.危重症患者单核细胞和中性粒细胞功能的免疫监测：从脓毒症和/或创伤到新型冠状病毒肺炎
J Clin Med. 2021 Dec 12;10(24):5815. doi: 10.3390/jcm10245815.
9
The gut in COVID-19.新冠疫情中的肠道情况
Intensive Care Med. 2021 Sep;47(9):1024-1027. doi: 10.1007/s00134-021-06461-8. Epub 2021 Jul 8.
10
And once the storm is over… ICM will remain the intensivist's beacon.一旦风暴过去……《重症监护医学》仍将是重症医学专家的灯塔。
Intensive Care Med. 2021 Jun;47(6):687-691. doi: 10.1007/s00134-021-06402-5. Epub 2021 Apr 28.

本文引用的文献

1
The WHO's chief scientist on a year of loss and learning.世界卫生组织首席科学家谈损失与收获的一年。
Nature. 2020 Dec;588(7839):583-585. doi: 10.1038/d41586-020-03556-y.
2
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
3
Intensive care for COVID-19 in low- and middle-income countries: research opportunities and challenges.低收入和中等收入国家的新冠重症监护：研究机遇与挑战
Intensive Care Med. 2021 Feb;47(2):226-229. doi: 10.1007/s00134-020-06285-y. Epub 2020 Nov 13.
4
COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland.COVID-19 重症监护中的情况：英格兰、威尔士和北爱尔兰首次疫情流行的流行病学。
Intensive Care Med. 2020 Nov;46(11):2035-2047. doi: 10.1007/s00134-020-06267-0. Epub 2020 Oct 9.
5
Organizational aspects of care associated with mortality in critically ill COVID-19 patients.危重症COVID-19患者护理的组织层面与死亡率的关系
Intensive Care Med. 2021 Jan;47(1):119-121. doi: 10.1007/s00134-020-06249-2. Epub 2020 Oct 6.
6
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.地塞米松对中重度 COVID-19 相关急性呼吸窘迫综合征患者存活天数和无呼吸机天数的影响：CoDEX 随机临床试验。
JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021.
7
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.COVID-19 重症患者全身使用皮质类固醇与死亡率的关联：一项荟萃分析。
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
8
Uncontrolled interventions during pandemics: a missed learning opportunity?大流行期间的无控制干预措施：错失的学习机会？
Intensive Care Med. 2020 Oct;46(10):1930-1931. doi: 10.1007/s00134-020-06180-6. Epub 2020 Jul 23.
9
Critical care journals during the COVID-19 pandemic: challenges and responsibilities.新冠疫情期间的重症监护期刊：挑战与责任
Intensive Care Med. 2020 Aug;46(8):1521-1523. doi: 10.1007/s00134-020-06155-7. Epub 2020 Jul 6.
10
Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies.COVID-19 患者重症监护的结局：观察性研究的系统评价和荟萃分析。
Anaesthesia. 2020 Oct;75(10):1340-1349. doi: 10.1111/anae.15201. Epub 2020 Jul 15.